TP53 and liver cancer: A correlation between mutation of p53 and p53 antibodies has been previously shown in ovarian, lung, colorectal, breast, and liver cancer patients, providing a potential explanation for the significantly higher level of immune system processes observed in MSI-High p53-Mut cell lines [44].